These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

205 related items for PubMed ID: 38127066

  • 1. Emerging variants of SARS-CoV-2 NSP10 highlight strong functional conservation of its binding to two non-structural proteins, NSP14 and NSP16.
    Wang H, Rizvi SRA, Dong D, Lou J, Wang Q, Sopipong W, Su Y, Najar F, Agarwal PK, Kozielski F, Haider S.
    Elife; 2023 Dec 21; 12():. PubMed ID: 38127066
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Structural and functional insights into the 2'-O-methyltransferase of SARS-CoV-2.
    Deng J, Gong F, Li Y, Tan X, Liu X, Yang S, Chen X, Wang H, Liu Q, Shen C, Zhou L, Chen Y.
    Virol Sin; 2024 Aug 21; 39(4):619-631. PubMed ID: 38969340
    [Abstract] [Full Text] [Related]

  • 4. New targets for drug design: importance of nsp14/nsp10 complex formation for the 3'-5' exoribonucleolytic activity on SARS-CoV-2.
    Saramago M, Bárria C, Costa VG, Souza CS, Viegas SC, Domingues S, Lousa D, Soares CM, Arraiano CM, Matos RG.
    FEBS J; 2021 Sep 21; 288(17):5130-5147. PubMed ID: 33705595
    [Abstract] [Full Text] [Related]

  • 5. Biochemical and structural insights into the mechanisms of SARS coronavirus RNA ribose 2'-O-methylation by nsp16/nsp10 protein complex.
    Chen Y, Su C, Ke M, Jin X, Xu L, Zhang Z, Wu A, Sun Y, Yang Z, Tien P, Ahola T, Liang Y, Liu X, Guo D.
    PLoS Pathog; 2011 Oct 21; 7(10):e1002294. PubMed ID: 22022266
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Localization of SARS-CoV-2 Capping Enzymes Revealed by an Antibody against the nsp10 Subunit.
    Horova V, Landova B, Hodek J, Chalupsky K, Krafcikova P, Chalupska D, Duchoslav V, Weber J, Boura E, Klima M.
    Viruses; 2021 Jul 29; 13(8):. PubMed ID: 34452352
    [Abstract] [Full Text] [Related]

  • 10. Substrate Specificity of SARS-CoV-2 Nsp10-Nsp16 Methyltransferase.
    Benoni R, Krafcikova P, Baranowski MR, Kowalska J, Boura E, Cahová H.
    Viruses; 2021 Aug 30; 13(9):. PubMed ID: 34578302
    [Abstract] [Full Text] [Related]

  • 11. Despite the odds: formation of the SARS-CoV-2 methylation complex.
    Matsuda A, Plewka J, Rawski M, Mourão A, Zajko W, Siebenmorgen T, Kresik L, Lis K, Jones AN, Pachota M, Karim A, Hartman K, Nirwal S, Sonani R, Chykunova Y, Minia I, Mak P, Landthaler M, Nowotny M, Dubin G, Sattler M, Suder P, Popowicz GM, Pyrć K, Czarna A.
    Nucleic Acids Res; 2024 Jun 24; 52(11):6441-6458. PubMed ID: 38499483
    [Abstract] [Full Text] [Related]

  • 12. Binding of the Methyl Donor S-Adenosyl-l-Methionine to Middle East Respiratory Syndrome Coronavirus 2'-O-Methyltransferase nsp16 Promotes Recruitment of the Allosteric Activator nsp10.
    Aouadi W, Blanjoie A, Vasseur JJ, Debart F, Canard B, Decroly E.
    J Virol; 2017 Mar 01; 91(5):. PubMed ID: 28031370
    [Abstract] [Full Text] [Related]

  • 13. Refolding of lid subdomain of SARS-CoV-2 nsp14 upon nsp10 interaction releases exonuclease activity.
    Czarna A, Plewka J, Kresik L, Matsuda A, Karim A, Robinson C, O'Byrne S, Cunningham F, Georgiou I, Wilk P, Pachota M, Popowicz G, Wyatt PG, Dubin G, Pyrć K.
    Structure; 2022 Aug 04; 30(8):1050-1054.e2. PubMed ID: 35609600
    [Abstract] [Full Text] [Related]

  • 14. Molecular Simulation-Based Investigation of Highly Potent Natural Products to Abrogate Formation of the nsp10-nsp16 Complex of SARS-CoV-2.
    Mohammad A, Alshawaf E, Marafie SK, Abu-Farha M, Al-Mulla F, Abubaker J.
    Biomolecules; 2021 Apr 14; 11(4):. PubMed ID: 33919870
    [Abstract] [Full Text] [Related]

  • 15. Coronavirus nsp10/nsp16 Methyltransferase Can Be Targeted by nsp10-Derived Peptide In Vitro and In Vivo To Reduce Replication and Pathogenesis.
    Wang Y, Sun Y, Wu A, Xu S, Pan R, Zeng C, Jin X, Ge X, Shi Z, Ahola T, Chen Y, Guo D.
    J Virol; 2015 Aug 14; 89(16):8416-27. PubMed ID: 26041293
    [Abstract] [Full Text] [Related]

  • 16. Characterization of the SARS-CoV-2 ExoN (nsp14ExoN-nsp10) complex: implications for its role in viral genome stability and inhibitor identification.
    Baddock HT, Brolih S, Yosaatmadja Y, Ratnaweera M, Bielinski M, Swift LP, Cruz-Migoni A, Fan H, Keown JR, Walker AP, Morris GM, Grimes JM, Fodor E, Schofield CJ, Gileadi O, McHugh PJ.
    Nucleic Acids Res; 2022 Feb 22; 50(3):1484-1500. PubMed ID: 35037045
    [Abstract] [Full Text] [Related]

  • 17. SS148 and WZ16 inhibit the activities of nsp10-nsp16 complexes from all seven human pathogenic coronaviruses.
    Li F, Ghiabi P, Hajian T, Klima M, Li ASM, Khalili Yazdi A, Chau I, Loppnau P, Kutera M, Seitova A, Bolotokova A, Hutchinson A, Perveen S, Boura E, Vedadi M.
    Biochim Biophys Acta Gen Subj; 2023 Apr 22; 1867(4):130319. PubMed ID: 36764586
    [Abstract] [Full Text] [Related]

  • 18. Analysis of critical protein-protein interactions of SARS-CoV-2 capping and proofreading molecular machineries towards designing dual target inhibitory peptides.
    Arabi-Jeshvaghani F, Javadi-Zarnaghi F, Ganjalikhany MR.
    Sci Rep; 2023 Jan 07; 13(1):350. PubMed ID: 36611052
    [Abstract] [Full Text] [Related]

  • 19. Crystal structure of SARS-CoV-2 nsp10-nsp16 in complex with small molecule inhibitors, SS148 and WZ16.
    Klima M, Khalili Yazdi A, Li F, Chau I, Hajian T, Bolotokova A, Kaniskan HÜ, Han Y, Wang K, Li D, Luo M, Jin J, Boura E, Vedadi M.
    Protein Sci; 2022 Sep 07; 31(9):e4395. PubMed ID: 36040262
    [Abstract] [Full Text] [Related]

  • 20. Reconstitution and functional characterization of SARS-CoV-2 proofreading complex.
    Ma Z, Pourfarjam Y, Kim IK.
    Protein Expr Purif; 2021 Sep 07; 185():105894. PubMed ID: 33933612
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.